Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$913M |
| 2 |
Meta Platforms (Facebook)
META
|
+$659M |
| 3 |
Caterpillar
CAT
|
+$450M |
| 4 |
PayPal
PYPL
|
+$435M |
| 5 |
Becton Dickinson
BDX
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$860M |
| 2 |
Humana
HUM
|
+$581M |
| 3 |
Goldman Sachs
GS
|
+$372M |
| 4 |
Boston Scientific
BSX
|
+$345M |
| 5 |
Walmart Inc
WMT
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.36% |
| 2 | Healthcare | 2.87% |
| 3 | Financials | 2.57% |
| 4 | Consumer Discretionary | 2.23% |
| 5 | Industrials | 2.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3551
CALL
Hyatt Hotels
H
$17.1B
| $5.75M | ﹤0.01% |
63,600
-143,700
| -69% | -$13.2M |
|
|
IMA
3552
ImageneBio Inc
IMA
$66.3M
| $5.73M | ﹤0.01% |
179,595
-278
| -0.2% | -$8.88K |
|
|
JUGG
3553
DELISTED
Jaws Juggernaut Acquisition Corporation Class A Ordinary Share
JUGG
| $5.73M | ﹤0.01% |
570,392
-200,085
| -26% | -$1.99M |
|
3554
PUT
Charles River Laboratories
CRL
$13.4B
| $5.73M | ﹤0.01% |
26,300
+16,100
| +158% | +$3.52M |
|
3555
Enpro
NPO
$7.27B
| $5.73M | ﹤0.01% |
52,701
+6,405
| +14% | +$693K |
|
3556
PUT
Helmerich & Payne
HP
$4.42B
| $5.73M | ﹤0.01% |
115,500
+19,600
| +20% | +$933K |
|
3557
AngioDynamics
ANGO
$655M
| $5.72M | ﹤0.01% |
415,659
+236,301
| +132% | +$3.29M |
|
|
FRC
3558
DELISTED
First Republic Bank
FRC
| $5.71M | ﹤0.01% |
46,886
-96,160
| -67% | -$11.7M |
|
3559
Harley-Davidson
HOG
$2.89B
| $5.71M | ﹤0.01% |
137,377
-27,539
| -17% | -$1.17M |
|
3560
MYR Group
MYRG
$5.21B
| $5.71M | ﹤0.01% |
62,014
+52,909
| +581% | +$4.8M |
|
3561
CALL
Everest Group
EG
$14.2B
| $5.7M | ﹤0.01% |
17,200
+400
| +2% | +$125K |
|
3562
CALL
Magnachip Semiconductor
MX
$139M
| $5.69M | ﹤0.01% |
606,300
-1,700
| -0.3% | -$16.4K |
|
3563
CALL
MarketAxess Holdings
MKTX
$5.72B
| $5.69M | ﹤0.01% |
20,400
-10,800
| -35% | -$2.78M |
|
|
XM
3564
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $5.69M | ﹤0.01% |
+548,077
| New | +$5.74M |
|
3565
PUT
Zimmer Biomet
ZBH
$19.2B
| $5.69M | ﹤0.01% |
44,600
-400
| -0.9% | -$46.4K |
|
3566
CALL
Neurocrine Biosciences
NBIX
$15.5B
| $5.69M | ﹤0.01% |
47,600
+17,800
| +60% | +$2.08M |
|
3567
iShares Core MSCI Total International Stock ETF
IXUS
$60.8B
| $5.68M | ﹤0.01% |
+98,215
| New | +$5.48M |
|
3568
CALL
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$629M
| $5.68M | ﹤0.01% |
40,175
+7,695
| +24% | +$1.07M |
|
3569
Vanguard S&P 500 ETF
VOO
$1.04T
| $5.68M | ﹤0.01% |
16,162
-6,821
| -30% | -$2.41M |
|
3570
PUT
Dycom Industries
DY
$12.6B
| $5.67M | ﹤0.01% |
60,600
+30,600
| +102% | +$3.08M |
|
3571
CALL
Guardant Health
GH
$21.1B
| $5.67M | ﹤0.01% |
208,300
-228,000
| -52% | -$10.4M |
|
3572
CALL
Golar LNG
GLNG
$5.36B
| $5.66M | ﹤0.01% |
248,500
-35,000
| -12% | -$876K |
|
|
CMA
3573
PUT
DELISTED
Comerica
CMA
| $5.66M | ﹤0.01% |
84,700
-35,300
| -29% | -$2.45M |
|
|
CHUY
3574
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $5.66M | ﹤0.01% |
199,838
+122,257
| +158% | +$3.54M |
|
3575
CALL
Waters Corp
WAT
$40.5B
| $5.65M | ﹤0.01% |
16,500
-2,900
| -15% | -$917K |
|
Similar funds
Ken Griffin's Q4 2022 Portfolio in Review
As of Q4 2022, Ken Griffin held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ken Griffin opened a new position in Denbury Inc. worth $107M.
- Ken Griffin's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
- Ken Griffin added most to Tesla in Q4 2022, an estimated $913M increase.
- Ken Griffin's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
- Ken Griffin fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
- Ken Griffin's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
- Ken Griffin opened 3,614 new positions and closed 1,312 in Q4 2022.
- Ken Griffin's portfolio value fell 2.4% quarter-over-quarter to $428B.
Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.